TruFin hails "strong" 2025 trading as revenue, profit advance
18th Mar 2026 14:24
(Alliance News) - TruFin PLC on Wednesday said initial revenue in 2026 has tracked its expectations, as it printed revenue and earnings gains in 2025. Read More
(Alliance News) - TruFin PLC on Wednesday said initial revenue in 2026 has tracked its expectations, as it printed revenue and earnings gains in 2025. Read More
(Alliance News) - Clarkson PLC on Wednesday said it has acquired North American physical crude and derivatives oil brokerage business and data provider Link Group in an all-cash deal. Read More
(Alliance News) - Manchester & London Investment Trust PLC on Wednesday said its net asset value per share total return was negative mostly due to Microsoft Corp, as it hailed the emergence of autonomous artificial intelligence agents as a "watershed moment" in its outlook. Read More
(Alliance News) - itim Group PLC on Wednesday said it expects to report a pretax loss for 2025, citing an impact by a bad debt of a retail customer going into administration in early 2026. Read More
(Alliance News) - BioPharma Credit PLC on Wednesday announced a new USD50 million investment in Paratek Pharmaceuticals Inc to fund the completion of the company's combination with Radius Health Inc. Read More
Oxford BioMedica PLC - Oxford, England-based gene and cell therapy developer - Enters a five-year licensing and option agreement with Viral Vector Manufacturing Facility, an Australian contract development and manufacturing organisation (CDMO) and "the country's first commercial manufacturing facility of its kind", having signed a non-binding terms sheet in October. VVMF will have a non-exclusive global licence to use Oxford BioMedica's inAAVate platform "know-how and intellectual property", and an option to extend the licence to the LentiVector platform. OXB says it will receive a low single-digit million licence fee and is eligible for future platform use payments. Expects the contract to enable VVMF "to accelerate its operational and commercial readiness to provide advanced viral vector technologies to customers, capturing global demand with a particular focus on the fast-growing APAC region, and positioning Australia as a regional hub for high‑quality cell and gene therapy manufacturing." Read More
(Alliance News) - Stock prices in London were higher at midday on Wednesday, as investors were calmed by reports of progress in restarting oil exports from the Middle East, and turned their attention to the upcoming US rate decision. Read More
(Alliance News) - FDM Group Holdings PLC on Wednesday announced that it is seeing increasing client appetite for artificial intelligence-enabled skills, as it noted that recent events in the Middle East added to economic uncertainty. Read More
(Correcting that Cusdin sold, not bought, shares). Read More
Costain Group PLC - Maidenhead, England-based construction and engineering company - Severn Trent PLC has selected Costain to deliver "critical infrastructure upgrades" at its Rugby Newbold Sewage Treatment Works, in a programme valued at around GBP45 million and set to run until 2028. Costain says it will be the principal designer and contractor, "designing and building new facilities and upgrading systems to improve operational resilience and increase the site's feed and storm capacity." Notes that the contract builds on the firms' existing partnership which started with a 2010 AMP5 framework contract. This "has since been extended through the AMP6, AMP7 and AMP8 regulatory cycles, taking the partnership to at least 2030." Read More
(Alliance News) - CK Infrastructure Holdings Ltd on Wednesday said it increased revenue and profit in its last full-year results that include contributions from UK Power Networks Holdings Ltd, set to be sold to by July. Read More
(Alliance News) - Rachel Reeves is courting Spanish investors in her first visit to the country as UK chancellor as she prioritises closer ties with Europe. Read More